Skip to content
aacr.org· AACR·· 2026-04-19Score60

Clinical Trial Results: Long-term Updates on Approved Immunotherapies

atezolizumab

In brief

A record 265 clinical trial abstracts fed five minisymposia. The 'Updates in Anticancer Immunotherapies' session covered atezolizumab in alveolar soft part sarcoma: 54 patients enrolled as of June 2025, with responses lasting 10 to 69 months.

Conference abstracts

Source: aacr.org · aacr.org

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org